Loading...
Status of adjuvant endocrine therapy for breast cancer
Adjuvant endocrine therapy reduces the risk of recurrence and death from breast cancer in women with hormone receptor-positive early breast cancer. Tamoxifen has been the standard therapy for decades, and this is still the case for pre-menopausal women. Ovarian suppression is of similar efficacy but...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4053079/ https://ncbi.nlm.nih.gov/pubmed/25032258 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr3636 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|